BioPharma Credit PLC (BPCP.L) Research
Operating as an investment trust since its founding in 2016 in Exeter, United Kingdom, BioPharma Credit PLC concentrates its investments on interest-bearing debt assets. These assets are financially backed by royalties or other revenue derived from the sales of established life sciences products.
Market snapshot
- Symbol
- BPCP.L
- Price
- $70.60
- Day change
- -0.56%
- Market cap
- $1.1B
- P/E ratio
- 8.38x
- 52-week range
- 0.6418-72.4
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Cordiant Digital Infrastructure Limited (CORD.L)
- Fidelity Emerging Markets Limited (FEML.L)
- Molten Ventures Plc (GROW.L)
- Impax Environmental Markets plc (IEM.L)
- Metro Bank PLC (MTRO.L)
- NB Private Equity Partners Limited (NBPE.L)
- Pollen Street Group Limited (POLN.L)
- Ruffer Investment Company Limited (RICA.L)
Open BioPharma Credit PLC (BPCP.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.